Uplands College is delighted to announce the remarkable achievements of the Matric Class of 2023, once again attaining a 100% ...

The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...

This year, TIME editors launch the TIME100 Companies: Industry Leaders lists, an expansion of the TIME100 Most Influential Companies issue that dives deeper into 20 sectors to look at the companies ...

David J. Adams serves as Indiana’s Secretary of Commerce and a member of Governor Mike Braun’s cabinet. Since his appointment in 2025, Adams has been instrumental in the transforming the state’s ...

April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities, as the startup deepens its push into the ‌life ...

The flow of Tomodachi Life: Living the Dream is straightforward: make Miis, give them items and friends to make them happy, then give them items to define their character more as they level up. While ...

Jessica hails from Northern Ireland, and has written thousands of guides across sites such as Eurogamer, PCGamer, IGN, and PCGamesN. She also ventures into the lands of reviews, news, interviews, and ...

One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life Sciences VI (BLXS VI) fund, which is 40% larger than its predecessor.

Blackstone Inc. closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing clinical trials of medicines and technologies. The new vehicle, Blackstone ...

April 16th: We updated our personality guide for the launch of Tomodachi Life: Living the Dream, as well as adding in the North American English variant personality names. The long-awaited sequel to ...

March 26 (Reuters) - Wave Life Sciences (WVE.O), opens new tab shares plunged 58% on Thursday after a higher dose of its experimental obesity ‌drug failed to show a clear improvement at reducing a ...